_id
6914879dccc777a4e85d9710
Ticker
OLMA
Name
Olema Pharmaceuticals Inc
Exchange
NASDAQ
Address
780 Brannan Street, San Francisco, CA, United States, 94103
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://olema.com
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. The company's lead product candidate is palazestrant, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 3 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer; OPERA-01, the pivotal Phase 3 clinical trial of palazestrant as a monotherapy in second/third-line ER+/HER2- metastatic breast cancer; and palazestrant with CDK4/6 inhibitors palbociclib and ribociclib, a phosphatidylinositol 3 kinase alpha (PI3Ka) inhibitor alpelisib, and with an mTOR inhibitor everolimus that is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive human epidermal growth factor receptor 2-negative breast cancer. It also develops OP-3136, an orally-available small molecule that potently and selectively inhibits KAT6 for patients with ER+/HER2- metastatic breast cancer and other cancers which is in Phase 1 clinical trial. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
Last Close
30.68
Volume
2156173
Current Price
32.06
Change
4.498044328552812
Last Updated
2025-12-02T13:02:40.985Z
Image
data:image/webp;base64,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
Ipo Date
2020-11-19T00:00:00.000Z
Market Cap
2240469760
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.814325
Sentiment Sources
16
Rating
4.625
Target Price
36.5
Strong Buy
5
Buy
3
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
45877000
Operating Income
-45877000
Interest Expense
-
Pretax Income
-42217000
Net Income
-42217000
Eps
-0.4924286284383091
Dividends Per Share
-
Shares Outstanding
80159923
Income Tax Expense
-
EBITDA
-42174000
Operating Margin
-
Total Other Income Expense Net
3660000
Cash
35260000
Short Term Investments
293700000
Receivables
2971000
Inventories
-
Total Current Assets
334329000
Property Plant Equipment
1905000
Total Assets
352453000
Payables
3474000
Short Term Debt
1168000
Long Term Debt
3000000
Total Liabilities
44965000
Equity
307488000
Depreciation
43000
Change In Working Capital
4418000
Cash From Operations
-34527000
Capital Expenditures
0
Cash From Investing
17273000
Cash From Financing
41000
Net Change In Cash
-17213000
PE
-
PB
8.938804133039339
ROE
-13.729641481944011
ROA
-11.978050974172442
FCF
-34527000
Fcf Percent
-
Piotroski FScore
1
Health Score
35
Deep Value Investing Score
3
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
1
Quality Investing Score
2.5
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
45877000
Quarters > 0 > income Statement > operating Income
-45877000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-42217000
Quarters > 0 > income Statement > net Income
-42217000
Quarters > 0 > income Statement > eps
-0.4924286284383091
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
85732221
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-42174000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
3660000
Quarters > 0 > balance Sheet > cash
35260000
Quarters > 0 > balance Sheet > short Term Investments
293700000
Quarters > 0 > balance Sheet > receivables
2971000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
334329000
Quarters > 0 > balance Sheet > property Plant Equipment
1905000
Quarters > 0 > balance Sheet > total Assets
352453000
Quarters > 0 > balance Sheet > payables
3474000
Quarters > 0 > balance Sheet > short Term Debt
1168000
Quarters > 0 > balance Sheet > long Term Debt
3000000
Quarters > 0 > balance Sheet > total Liabilities
44965000
Quarters > 0 > balance Sheet > equity
307488000
Quarters > 0 > cash Flow > net Income
-42217000
Quarters > 0 > cash Flow > depreciation
43000
Quarters > 0 > cash Flow > change In Working Capital
4418000
Quarters > 0 > cash Flow > cash From Operations
-34527000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
17273000
Quarters > 0 > cash Flow > cash From Financing
41000
Quarters > 0 > cash Flow > net Change In Cash
-17213000
Quarters > 0 > ratios > PE
-0.4924286284383091
Quarters > 0 > ratios > PB
8.938804133039339
Quarters > 0 > ratios > ROE
-13.729641481944011
Quarters > 0 > ratios > ROA
-11.978050974172442
Quarters > 0 > ratios > FCF
-34527000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
47864000
Quarters > 1 > income Statement > operating Income
-47864000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-43784000
Quarters > 1 > income Statement > net Income
-43784000
Quarters > 1 > income Statement > eps
-0.5121089844272037
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
85497426
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-47732000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
4080000
Quarters > 1 > balance Sheet > cash
52473000
Quarters > 1 > balance Sheet > short Term Investments
309440000
Quarters > 1 > balance Sheet > receivables
2746000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
367725000
Quarters > 1 > balance Sheet > property Plant Equipment
2245000
Quarters > 1 > balance Sheet > total Assets
382002000
Quarters > 1 > balance Sheet > payables
934000
Quarters > 1 > balance Sheet > short Term Debt
1153000
Quarters > 1 > balance Sheet > long Term Debt
3000000
Quarters > 1 > balance Sheet > total Liabilities
36766000
Quarters > 1 > balance Sheet > equity
345236000
Quarters > 1 > cash Flow > net Income
-43784000
Quarters > 1 > cash Flow > depreciation
132000
Quarters > 1 > cash Flow > change In Working Capital
10502000
Quarters > 1 > cash Flow > cash From Operations
-29883000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
34234000
Quarters > 1 > cash Flow > cash From Financing
-2518000
Quarters > 1 > cash Flow > net Change In Cash
1833000
Quarters > 1 > ratios > PE
-0.5121089844272037
Quarters > 1 > ratios > PB
7.939633982435204
Quarters > 1 > ratios > ROE
-12.682339037643814
Quarters > 1 > ratios > ROA
-11.461720095706305
Quarters > 1 > ratios > FCF
-29883000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
128000
Quarters > 2 > income Statement > gross Profit
-128000
Quarters > 2 > income Statement > operating Expenses
34873000
Quarters > 2 > income Statement > operating Income
-34873000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-30389000
Quarters > 2 > income Statement > net Income
-30389000
Quarters > 2 > income Statement > eps
-0.3557338593794554
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
85426223
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-34745000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
4484000
Quarters > 2 > balance Sheet > cash
50640000
Quarters > 2 > balance Sheet > short Term Investments
342067000
Quarters > 2 > balance Sheet > receivables
1920000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
396663000
Quarters > 2 > balance Sheet > property Plant Equipment
1708000
Quarters > 2 > balance Sheet > total Assets
409639000
Quarters > 2 > balance Sheet > payables
151000
Quarters > 2 > balance Sheet > short Term Debt
1025000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
26187000
Quarters > 2 > balance Sheet > equity
383452000
Quarters > 2 > cash Flow > net Income
-30389000
Quarters > 2 > cash Flow > depreciation
128000
Quarters > 2 > cash Flow > change In Working Capital
-16282000
Quarters > 2 > cash Flow > cash From Operations
-43979000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-45083000
Quarters > 2 > cash Flow > cash From Financing
222000
Quarters > 2 > cash Flow > net Change In Cash
-88840000
Quarters > 2 > ratios > PE
-0.3557338593794554
Quarters > 2 > ratios > PB
7.142392553383475
Quarters > 2 > ratios > ROE
-7.9251118784098145
Quarters > 2 > ratios > ROA
-7.418483103415446
Quarters > 2 > ratios > FCF
-43979000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
364000
Quarters > 3 > income Statement > cost Of Revenue
182000
Quarters > 3 > income Statement > gross Profit
182000
Quarters > 3 > income Statement > operating Expenses
36768000
Quarters > 3 > income Statement > operating Income
-36768000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-33567000
Quarters > 3 > income Statement > net Income
-33567000
Quarters > 3 > income Statement > eps
-0.5714161980277587
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
58743522
Quarters > 3 > income Statement > income Tax Expense
3352000
Quarters > 3 > income Statement > EBITDA
-36652000
Quarters > 3 > income Statement > operating Margin
-10101.098901098901
Quarters > 3 > income Statement > total Other Income Expense Net
3201000
Quarters > 3 > balance Sheet > cash
139480000
Quarters > 3 > balance Sheet > short Term Investments
294606000
Quarters > 3 > balance Sheet > receivables
2120000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
438473000
Quarters > 3 > balance Sheet > property Plant Equipment
2060000
Quarters > 3 > balance Sheet > total Assets
450979000
Quarters > 3 > balance Sheet > payables
4460000
Quarters > 3 > balance Sheet > short Term Debt
1172000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
42015000
Quarters > 3 > balance Sheet > equity
408964000
Quarters > 3 > cash Flow > net Income
-33567000
Quarters > 3 > cash Flow > depreciation
116000
Quarters > 3 > cash Flow > change In Working Capital
2176000
Quarters > 3 > cash Flow > cash From Operations
-26284000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-114424000
Quarters > 3 > cash Flow > cash From Financing
244300000
Quarters > 3 > cash Flow > net Change In Cash
103592000
Quarters > 3 > ratios > PE
-0.5714161980277587
Quarters > 3 > ratios > PB
4.605093150790779
Quarters > 3 > ratios > ROE
-8.207812912628007
Quarters > 3 > ratios > ROA
-7.443140367955049
Quarters > 3 > ratios > FCF
-26284000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-72.20879120879121
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
393000
Annuals > 0 > income Statement > gross Profit
-393000
Annuals > 0 > income Statement > operating Expenses
142258000
Annuals > 0 > income Statement > operating Income
-142258000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-129474000
Annuals > 0 > income Statement > net Income
-129474000
Annuals > 0 > income Statement > eps
-2.204055793590313
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
58743522
Annuals > 0 > income Statement > income Tax Expense
-1
Annuals > 0 > income Statement > EBITDA
-141865000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
12784000
Annuals > 0 > balance Sheet > cash
139480000
Annuals > 0 > balance Sheet > short Term Investments
294606000
Annuals > 0 > balance Sheet > receivables
2120000
Annuals > 0 > balance Sheet > inventories
-4021000
Annuals > 0 > balance Sheet > total Current Assets
438473000
Annuals > 0 > balance Sheet > property Plant Equipment
2060000
Annuals > 0 > balance Sheet > total Assets
450979000
Annuals > 0 > balance Sheet > payables
4460000
Annuals > 0 > balance Sheet > short Term Debt
1172000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
42015000
Annuals > 0 > balance Sheet > equity
408964000
Annuals > 0 > cash Flow > net Income
-129474000
Annuals > 0 > cash Flow > depreciation
393000
Annuals > 0 > cash Flow > change In Working Capital
9164000
Annuals > 0 > cash Flow > cash From Operations
-104351000
Annuals > 0 > cash Flow > capital Expenditures
159000
Annuals > 0 > cash Flow > cash From Investing
-93526000
Annuals > 0 > cash Flow > cash From Financing
268818000
Annuals > 0 > cash Flow > net Change In Cash
70941000
Annuals > 0 > ratios > PE
-2.204055793590313
Annuals > 0 > ratios > PB
4.014733423724337
Annuals > 0 > ratios > ROE
-31.659021331950974
Annuals > 0 > ratios > ROA
-28.709540799017248
Annuals > 0 > ratios > FCF
-104510000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
377000
Annuals > 1 > income Statement > gross Profit
-377000
Annuals > 1 > income Statement > operating Expenses
104961000
Annuals > 1 > income Statement > operating Income
-104961000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-96655000
Annuals > 1 > income Statement > net Income
-96655000
Annuals > 1 > income Statement > eps
-2.136159096877329
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
45247098
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-104584000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
8306000
Annuals > 1 > balance Sheet > cash
68539000
Annuals > 1 > balance Sheet > short Term Investments
193268000
Annuals > 1 > balance Sheet > receivables
673000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
266513000
Annuals > 1 > balance Sheet > property Plant Equipment
3259000
Annuals > 1 > balance Sheet > total Assets
276945000
Annuals > 1 > balance Sheet > payables
2698000
Annuals > 1 > balance Sheet > short Term Debt
988000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
23050000
Annuals > 1 > balance Sheet > equity
253895000
Annuals > 1 > cash Flow > net Income
-96655000
Annuals > 1 > cash Flow > depreciation
377000
Annuals > 1 > cash Flow > change In Working Capital
-589000
Annuals > 1 > cash Flow > cash From Operations
-83727000
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-4851000
Annuals > 1 > cash Flow > cash From Financing
133415000
Annuals > 1 > cash Flow > net Change In Cash
44837000
Annuals > 1 > ratios > PE
-2.136159096877329
Annuals > 1 > ratios > PB
4.981021245396719
Annuals > 1 > ratios > ROE
-38.06888674452038
Annuals > 1 > ratios > ROA
-34.900431493617866
Annuals > 1 > ratios > FCF
-83727000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
29
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
1658000
Annuals > 2 > income Statement > gross Profit
-1658000
Annuals > 2 > income Statement > operating Expenses
106988000
Annuals > 2 > income Statement > operating Income
-106988000
Annuals > 2 > income Statement > interest Expense
357000
Annuals > 2 > income Statement > pretax Income
-104787000
Annuals > 2 > income Statement > net Income
-102586000
Annuals > 2 > income Statement > eps
-2.564941120817213
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
39995460
Annuals > 2 > income Statement > income Tax Expense
-2201000
Annuals > 2 > income Statement > EBITDA
-106631000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
2201000
Annuals > 2 > balance Sheet > cash
23702000
Annuals > 2 > balance Sheet > short Term Investments
180719000
Annuals > 2 > balance Sheet > receivables
319000
Annuals > 2 > balance Sheet > inventories
-319000
Annuals > 2 > balance Sheet > total Current Assets
208899000
Annuals > 2 > balance Sheet > property Plant Equipment
3975000
Annuals > 2 > balance Sheet > total Assets
215645000
Annuals > 2 > balance Sheet > payables
374000
Annuals > 2 > balance Sheet > short Term Debt
1015000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
18099000
Annuals > 2 > balance Sheet > equity
197546000
Annuals > 2 > cash Flow > net Income
-104787000
Annuals > 2 > cash Flow > depreciation
1658000
Annuals > 2 > cash Flow > change In Working Capital
3022000
Annuals > 2 > cash Flow > cash From Operations
-82065000
Annuals > 2 > cash Flow > capital Expenditures
363000
Annuals > 2 > cash Flow > cash From Investing
91479000
Annuals > 2 > cash Flow > cash From Financing
476000
Annuals > 2 > cash Flow > net Change In Cash
9890000
Annuals > 2 > ratios > PE
-2.564941120817213
Annuals > 2 > ratios > PB
5.658798998714223
Annuals > 2 > ratios > ROE
-51.93018334970083
Annuals > 2 > ratios > ROA
-47.57170349416865
Annuals > 2 > ratios > FCF
-82428000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
1663000
Annuals > 3 > income Statement > gross Profit
-1663000
Annuals > 3 > income Statement > operating Expenses
71491000
Annuals > 3 > income Statement > operating Income
-71491000
Annuals > 3 > income Statement > interest Expense
232000
Annuals > 3 > income Statement > pretax Income
-71096000
Annuals > 3 > income Statement > net Income
-71096000
Annuals > 3 > income Statement > eps
-1.79879340978121
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
39524272
Annuals > 3 > income Statement > income Tax Expense
-210000
Annuals > 3 > income Statement > EBITDA
-71328000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
395000
Annuals > 3 > balance Sheet > cash
13812000
Annuals > 3 > balance Sheet > short Term Investments
273438000
Annuals > 3 > balance Sheet > receivables
130000
Annuals > 3 > balance Sheet > inventories
-353000
Annuals > 3 > balance Sheet > total Current Assets
290685000
Annuals > 3 > balance Sheet > property Plant Equipment
4720000
Annuals > 3 > balance Sheet > total Assets
295945000
Annuals > 3 > balance Sheet > payables
23000
Annuals > 3 > balance Sheet > short Term Debt
931000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
11377000
Annuals > 3 > balance Sheet > equity
284568000
Annuals > 3 > cash Flow > net Income
-71096000
Annuals > 3 > cash Flow > depreciation
1663000
Annuals > 3 > cash Flow > change In Working Capital
2830000
Annuals > 3 > cash Flow > cash From Operations
-50690000
Annuals > 3 > cash Flow > capital Expenditures
1575000
Annuals > 3 > cash Flow > cash From Investing
-275438000
Annuals > 3 > cash Flow > cash From Financing
1391000
Annuals > 3 > cash Flow > net Change In Cash
-324737000
Annuals > 3 > ratios > PE
-1.79879340978121
Annuals > 3 > ratios > PB
3.882036639397262
Annuals > 3 > ratios > ROE
-24.98383514660819
Annuals > 3 > ratios > ROA
-24.023382723141122
Annuals > 3 > ratios > FCF
-52265000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
29
Valuation > metrics > PE
-0.4924286284383091
Valuation > metrics > PB
8.938804133039339
Valuation > final Score
20
Valuation > verdict
198.0% Overvalued
Profitability > metrics > ROE
-13.729641481944011
Profitability > metrics > ROA
-12.62738200993632
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.1462333489436986
Risk > metrics > Interest Coverage
-1066.906976744186
Risk > final Score
-4208
Risk > verdict
High
Liquidity > metrics > Current Ratio
72.02261956053425
Liquidity > metrics > Quick Ratio
72.02261956053425
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
33.94906849209221
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
12
Prev Risks > 1
28
Prev Risks > 2
12
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-12T00:51:53.061Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-02
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.5387
Earnings History > 0 > eps Difference
0.5387
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-10
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.49
Earnings History > 1 > eps Estimate
-0.4702
Earnings History > 1 > eps Difference
-0.0198
Earnings History > 1 > surprise Percent
-4.211
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-11
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.51
Earnings History > 2 > eps Estimate
-0.38
Earnings History > 2 > eps Difference
-0.13
Earnings History > 2 > surprise Percent
-34.2105
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-06
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.36
Earnings History > 3 > eps Estimate
-0.55
Earnings History > 3 > eps Difference
0.19
Earnings History > 3 > surprise Percent
34.5455
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-10
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.51
Earnings History > 4 > eps Estimate
0.1732
Earnings History > 4 > eps Difference
-0.6832
Earnings History > 4 > surprise Percent
-394.4573
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-05
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.6
Earnings History > 5 > eps Estimate
-0.58
Earnings History > 5 > eps Difference
-0.02
Earnings History > 5 > surprise Percent
-3.4483
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-06
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.54
Earnings History > 6 > eps Estimate
-0.55
Earnings History > 6 > eps Difference
0.01
Earnings History > 6 > surprise Percent
1.8182
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-08
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.56
Earnings History > 7 > eps Estimate
-0.55
Earnings History > 7 > eps Difference
-0.01
Earnings History > 7 > surprise Percent
-1.8182
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-11
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.49
Earnings History > 8 > eps Estimate
-0.48
Earnings History > 8 > eps Difference
-0.01
Earnings History > 8 > surprise Percent
-2.0833
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-07
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.48
Earnings History > 9 > eps Estimate
-0.51
Earnings History > 9 > eps Difference
0.03
Earnings History > 9 > surprise Percent
5.8824
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-08
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.49
Earnings History > 10 > eps Estimate
-0.73
Earnings History > 10 > eps Difference
0.24
Earnings History > 10 > surprise Percent
32.8767
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-09
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.7
Earnings History > 11 > eps Estimate
-0.66
Earnings History > 11 > eps Difference
-0.04
Earnings History > 11 > surprise Percent
-6.0606
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-09
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.65
Earnings History > 12 > eps Estimate
-0.65
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
0
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-08
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.57
Earnings History > 13 > eps Estimate
-0.77
Earnings History > 13 > eps Difference
0.2
Earnings History > 13 > surprise Percent
25.974
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-09
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.82
Earnings History > 14 > eps Estimate
-0.64
Earnings History > 14 > eps Difference
-0.18
Earnings History > 14 > surprise Percent
-28.125
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-09
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.58
Earnings History > 15 > eps Estimate
-0.57
Earnings History > 15 > eps Difference
-0.01
Earnings History > 15 > surprise Percent
-1.7544
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-02-28
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.54
Earnings History > 16 > eps Estimate
-0.49
Earnings History > 16 > eps Difference
-0.05
Earnings History > 16 > surprise Percent
-10.2041
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-10
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.45
Earnings History > 17 > eps Estimate
-0.46
Earnings History > 17 > eps Difference
0.01
Earnings History > 17 > surprise Percent
2.1739
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-10
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.42
Earnings History > 18 > eps Estimate
-0.38
Earnings History > 18 > eps Difference
-0.04
Earnings History > 18 > surprise Percent
-10.5263
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-11
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.39
Earnings History > 19 > eps Estimate
-0.28
Earnings History > 19 > eps Difference
-0.11
Earnings History > 19 > surprise Percent
-39.2857
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-17
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.5
Earnings History > 20 > eps Estimate
-0.18
Earnings History > 20 > eps Difference
-0.32
Earnings History > 20 > surprise Percent
-177.7778
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-11-19
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.03
Earnings History > 21 > eps Estimate
-0.5
Earnings History > 21 > eps Difference
0.47
Earnings History > 21 > surprise Percent
94
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. The company's lead product candidate is palazestrant, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 3 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer; OPERA-01, the pivotal Phase 3 clinical trial of palazestrant as a monotherapy in second/third-line ER+/HER2- metastatic breast cancer; and palazestrant with CDK4/6 inhibitors palbociclib and ribociclib, a phosphatidylinositol 3 kinase alpha (PI3Ka) inhibitor alpelisib, and with an mTOR inhibitor everolimus that is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive human epidermal growth factor receptor 2-negative breast cancer. It also develops OP-3136, an orally-available small molecule that potently and selectively inhibits KAT6 for patients with ER+/HER2- metastatic breast cancer and other cancers which is in Phase 1 clinical trial. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AOlema Pharmaceuticals (OLMA): Reassessing Valuation After Roche’s Phase 3 SERD Success Boosts Palazestrant Expectations simplywall.st
Read more →Oppenheimer Raises Price Target for Olema Pharmaceuticals (OLMA) to $48 | OLMA Stock News GuruFocus
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$36.5
Analyst Picks
Strong Buy
5
Buy
3
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 107.97% of the total shares of Olema Pharmaceuticals Inc
1.
Bain Capital Life Sciences Investors, LLC(9.9716%)
since
2025/06/30
2.
Paradigm Biocapital Advisors LP(9.8554%)
since
2025/06/30
3.
Bvf Inc(7.7161%)
since
2025/06/30
4.
BlackRock Inc(6.7096%)
since
2025/06/30
5.
Woodline Partners LP(5.1081%)
since
2025/06/30
6.
Deep Track Capital, LP(5.0162%)
since
2025/06/30
7.
Vanguard Group Inc(4.76%)
since
2025/06/30
8.
Logos Global Management LP(4.6753%)
since
2025/06/30
9.
HHG PLC(4.4042%)
since
2025/06/30
10.
Franklin Resources Inc(4.3884%)
since
2025/06/30
11.
MPM Oncology Impact Management LP(3.4658%)
since
2025/06/30
12.
Vanguard Total Stock Mkt Idx Inv(2.8558%)
since
2025/07/31
13.
Lightspeed Management Co LLC(2.8133%)
since
2025/06/30
14.
Pictet Asset Manangement SA(2.7377%)
since
2025/06/30
15.
Citadel Advisors Llc(2.4887%)
since
2025/06/30
16.
Vivo Capital, LLC(2.194%)
since
2025/06/30
17.
iShares Russell 2000 ETF(2.1141%)
since
2025/08/31
18.
Morgan Stanley - Brokerage Accounts(2.0943%)
since
2025/06/30
19.
UBS Group AG(2.0574%)
since
2025/06/30
20.
Geode Capital Management, LLC(1.9322%)
since
2025/06/30
21.
Franklin Biotechnology Discv A(acc)USD(1.926%)
since
2025/08/31
22.
Millennium Management LLC(1.852%)
since
2025/06/30
23.
Dimensional Fund Advisors, Inc.(1.7588%)
since
2025/06/30
24.
Pictet-Biotech P USD(1.3572%)
since
2025/05/31
25.
Franklin US Small Cap Growth Equity(1.3372%)
since
2025/06/30
26.
Franklin Small Cap Growth Adv(1.3014%)
since
2025/07/31
27.
Belfius Equities Cure C Cap(1.2391%)
since
2025/08/31
28.
Pictet-Global Megatrend Sel I USD(1.1593%)
since
2025/05/31
29.
Columbia Small Cap Value Discv A(1.1344%)
since
2025/07/31
30.
Franklin Biotechnology Discovery A(1.1251%)
since
2025/07/31
31.
Columbia Small Cap Value Discovery Fund(1.1033%)
since
2025/06/30
32.
International Biotechnology Ord(0.9007%)
since
2025/07/31
33.
Fidelity Small Cap Index(0.8717%)
since
2025/06/30
34.
iShares Russell 2000 Value ETF(0.7525%)
since
2025/08/31
35.
Vanguard Institutional Extnd Mkt Idx Tr(0.7468%)
since
2025/07/31
36.
iShares Biotechnology ETF(0.4501%)
since
2025/08/31
37.
Vanguard Russell 2000 ETF(0.4157%)
since
2025/07/31
38.
Pier Capital Small Cap Growth Equity(0.4027%)
since
2025/06/30
39.
SEB Nordamerikafond Småbolag(0.3932%)
since
2025/07/31
40.
Fidelity Extended Market Index(0.3823%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.5387
Date
2025-09-30
EPS Actual
-0.49
EPS Estimate
-0.4702
EPS Difference
-0.0198
Surprise Percent
-4.211%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.